Skip to main content Skip to search Skip to main navigation

Rouging When Stainless Steel Corrodes

Excerpt form the GMP Compliance Adviser, Chapter 5.E Operation and maintenance of water systems

12 min. reading time | by Herbert Bendlin
Published in LOGFILE 10/2021

What is rouging?

Rouging is a phenomenon that frequently occurs in water systems constructed from austenitic CrNi steel. The causes of rouging have been largely clarified. The mechanism of rouging formation and the parameters that have an influence have been described in the literature. The ISPE Newsletter No.1 (2007)1 and a number of different expert articles (see 5.H References) contain detailed descriptions of the phenomenon. It has been shown that a ferrite content up to 3% does not have a significant impact on the occurrence of rouging.

The GMP regulations do not cover rouging. The ISPE Baseline Water and Steam contains a small amount of information which is not very helpful. It recommends reducing the temperature and protecting the system through regular cleaning and repassivation. The latter has proven successful in practice.

In order to understand the phenomenon of rouging, knowledge about the surface of stainless steel is helpful. Stainless steel surfaces that do not show signs of corrosion are always shiny and with no sign of deposits. A transparent passive film which is 1–3 nm thick and contains a large amount of chromium oxide provides sufficient and reliable protection from corrosive interactions.

Figure 5.E-3 contains a schematic representation of the chemical and physical interactions. Figure 5.E-4 shows the protective effect of the film and the damage caused by corrosion.

Figure 5.E-3 Structure of the passive film on stainless steel alloys


Figure 5.E-4 Schematic representation of a metal surface with intact passive film (left) and with a partially damaged passive film and (the start of) corrosion (right) (Source: Henkel Beiz- und Elektropoliertechnik GmbH & Co.KG, 19306 Neustadt-Glewe, Germany)

The positive properties of an intact passive film include:

  • prevention of corrosion under normal conditions
  • quick and safe surface restoration (repassivation) if sufficient chrome and oxygen is available
  • impermeable for ions (e.g. chloride ions)

If the passive film is damaged or removed, normal oxidation occurs on the iron-chrome alloy. This is immediately recognisable as a reddish brown particulate precipitate on surfaces in hot ultrapure water systems (Figure 5.E-5).

This type of rouge coating is easily wiped off. The flowing medium transports the rouge particles through the entire pipeline into the dead spaces, pumps and containers where they are deposited. In pure steam systems, the rouge that forms can be strongly adherent. This deposit is dark purple (Figure 5.E-6 ).

 

Figure 5.E-5 Rouging in a WFI (water for injection) system (source: Henkel Beiz- und Elektropoliertechnik GmbH & Co.KG, 19306 Neustadt-Glewe, Germany)

 

Figure 5.E-6 Rouging in a pure steam generator (source: Ciba Spezialitätenchemie AG)

The destruction or removal of the passive film can have many different causes. If the temperature is high (e.g. above 80 °C), the ambient oxygen decreases. There is not enough oxygen to form chromium oxide. The passive film deteriorates and finally disappears (thermodynamic equilibrium). High temperatures also promote the breakdown of water into its component parts. These breakdown products (hydrogen ions H+ and hydroxide ions OH-) can also destroy the passive film because of a slight decrease in the pH value. Rouging occurs on all of the stainless steel types traditionally used in pharmaceutical facilities, e.g. 1.4435, 1.4404 and 1.4571. This is obvious from the information given above.

1 www.ispe-dach.org, Newsletter No. 1, April 2007, Rouging


How does rouging impact the water quality?

The coloured precipitates are, in chemical terms, different types of iron oxide and iron hydroxide. However, Cr and Ni-oxides or hydroxides are also present. Because the ions of these compounds are practically insoluble in water, it is not possible to detect iron ions which would mean that the water does not meet the quality requirements. A change in the specific conductivity cannot be observed either. This means that water from pipes with moderate rouging is chemically acceptable if we use the monographs in the pharmacopoeias as a reference. Even the limit value for the heavy metal content is not reached, or exceeded. The various specifications for the quality of pharmaceutical water do not contain a limit value for particles.

 

Figure 5.E-7 Reddish-brown deposits in a PTFE seal. The rouge particles transported in the WFI have been deposited on the seal. (Source: Henkel Beiz- und Elektropoliertechnik GmbH & Co.KG, 19306 Neustadt-Glewe, Germany)

The introduction and distribution of rouge particles from water and steam systems to production/media systems and facilities represents a particular problem. There is then a real risk that the particles will be transported into the product (the usual size of rouge particles ranges from 0.01 to 10 µm). The system must therefore be strictly controlled. If rouging occurs, suitable measures must be put in place. Rouging can often be detected on the seals (Teflon) of open systems because this is where the transported particles tend to accumulate (see Figure 5.E-7 ). As the particles are usually very small, they cannot be seen with the naked eye. Visible particles are usually larger than 50 µm.


How can rouging be addressed?

The EU GMP Guidelines state that the design, implementation and maintenance of premises and equipment must ensure that they are suitable for the intended process steps. But what happens when it is known that a material may release particles into the water and cause contamination? Rouging is a problem that should be taken into consideration during the validation or requalification of a system, and possible actions should be discussed and documented.

In practice, however, rouging is often ignored during the risk analysis and system qualification. One reason for this is that there is no great desire to include the issue in the documentation despite a proactive approach to the problem being good manufacturing practice. Despite the latest technology, rouging cannot be prevented if stainless steel is used. PVDF might be a suitable alternative. However, this material has not yet been accepted by the pharmaceutical industry, and there are technical uncertainties, with regard to hot water systems (thermal expansion), in particular.

As rouging is to be expected in hot pharmaceutical water systems, in particular, the system documentation should always cover the subject. If possible, rouging should be discussed at the planning stage. Possible measures should be documented during the risk analysis and taken into consideration during maintenance and cleaning (derouging and repassivation). In new systems, the use of electropolished surfaces can provide sufficient protection. For existing systems, accurate monitoring and documentation is recommended. Regular inspections carried out using specially installed equipment can help detect the problem at an early stage. If required, cleaning (derouging) and repassivation of the system can be carried out to restore the initial state.

The ability of rouge particles to migrate in systems that carry liquid means that rouging is not just a corrosion problem; it can also cause problems during pharmaceutical manufacture. Released particles cause an unwanted and unpredictable contamination of media and products. For this reason, a risk analysis should be carried out in each individual case to determine the impact of rouging on the quality of the manufactured products.

How can rouging be detected?

A device for measuring the rouging class is available. This inline device measures the reflectance of surfaces and the intensity of the reflected light. Polished surfaces reflect more light than surfaces that are stained with iron oxide and covered in rouging particles. The different possible states of a rouging surface are compared with the measured values, and the result is displayed (Figure 5.E-8 ).

 

Figure 5.E-8 Rouge monitoring in pharmaceutical water systems using the HPLG (Henkel Passive Layer Guard); left: schematic representation of the rouge display; right: practical use (source: Henkel Beiz- und Elektropoliertechnik GmbH & Co.KG. 19306 Neustadt-Glewe, Germany)

The starting point is a metal surface with a shiny finish or an electropolished surface (1). Rouge formation begins with a reduction in the passive layer (2) which leads to some initial staining of the surface - the beginning of rouging (3). When rouging increases, the alarm level is increased  (4). Cleaning (derouging) and repassivation of the system should be carried out when alarm level red (5) is reached at the latest.

This relatively simple measurement makes it possible to monitor rouge formation at all times. The authorities can also see that the operator of the system proactively addresses monitoring and rouging.

Rouging can also be monitored by controlling the number of particles. This is a state-of-the-art process used in the electronics industry and is an integral part of quality control in that industry. These types of control could also be implemented in pharmaceutical water systems with very little technical effort. However, they are rarely used in the pharmaceutical industry.


Do you have any questions or suggestions? Please contact us at: redaktion@gmp-verlag.de

Dr. Herbert Bendlin
Dr. Herbert Bendlin

You may also be interested in the following articles:

Swissmedic Updates Guidance on GMP Compliance of Foreign Manufacturers

Swissmedic Updates Guidance on GMP Compliance of Foreign Manufacturers

Swissmedic has revised its guidance document “GMP compliance by foreign manufacturers”. The new Version 7.0 has been valid since 7 September 2026. In particular, it introduces new provisions for demonstrating the GMP compliance of manufacturers inspected by the US FDA. 
Read more
Swissmedic Updates Requirements for Cooperation with Pre-Wholesalers

Swissmedic Updates Requirements for Cooperation with Pre-Wholesalers

Swissmedic has revised its Technical Interpretation “Market release and distribution in cooperation with a pre-wholesaler”. The document addresses market release and distribution where a Marketing Authorisation Holder works with a pre-wholesaler (logistics and distribution service provider).
Read more
News: Europe

IPEC Updates Two Guides on Pharmaceutical Excipients

The IPEC Federation has updated two key guides on pharmaceutical excipients. The IPEC Composition Guide for Pharmaceutical Excipients (Version 3, 2026) describes an approach for manufacturers to establish excipient composition profiles. The revised version now covers biotechnology- and fermentation-derived excipients, provides further details on component types and physicochemical characterisation, and includes an example composition profile template.
Read more
Applying the FDA’s 7-Step Model for AI/ML Validation in GMP Environments: One Year Later

Applying the FDA’s 7-Step Model for AI/ML Validation in GMP Environments: One Year Later

Artificial intelligence is becoming increasingly important in GMP-regulated environments, presenting companies with new regulatory challenges. This article summarizes the latest regulatory developments, introduces a validation framework based on the FDA's seven-step model, and outlines initial practical experience with AI/ML validation.

Read more
Question of the Week | GMP-Verlag

What are the General Requirements for Standard Documents?

Here's the answer:
Read more
News: Europe

EDQM: Revised Guidance on Sister File Applications

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has revised its Guidance on applications for “sister files” (PA/PH/CEP (09) 141). The revision is intended to support consistent application of the procedure and provide greater clarity on the classification and assessment of the corresponding CEP applications.
Read more
Previous
Next

Related Products

Skip product gallery
GMP Compliance Adviser | Named User Licence | 12M

GMP Compliance Adviser | Named User Licence | 12M

The GMP Compliance Adviser is an online publication that covers all aspects of Good Manufacturing Practice (GMP) in one source.In the GMP Compliance Adviser you’ll find: GMP in Practice This part contains 21 chapters with GMP expert knowledge to base your decisions upon. It provides practical assistance with checklists, templates and SOP examples. It is written by more than 80 authors with hands-on experience directly linked to the industry. The individual chapters describe the different aspects of GMP in clear language. Technical, organizational and procedural aspects are covered.More than 700 checklists, templates and examples of standard operation procedures taken directly out of practice help you in understanding the GMP requirements.GMP RegulationsThese chapters cover the most important GMP regulations from Europe and the United States (CFR and FDA), but also PIC/S, ICH, WHO and many more.  Sample Documents In addition, the GMP Compliance Adviser contains many sample documents and practical examples that you can use.

delivery time appr. 2-5 workdays after receipt of payment
€1,368.00 net excl. VAT
GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

Your knowledge portal for GDP-compliant pharmaceutical logistics.  It is important that you as a logistics service provider, but also as a client in the pharmaceutical industry, comply with regulatory requirements. The GMP:KnowHow knowledge portal guides you through the complex regulatory landscape of the pharmaceutical and logistical supply chain! The knowledge portal gives you an easy-to-understand overview of all the important topics. Interactive graphics help you navigate all areas covered by the EU GDP Guidelines (2013/C 343/01). You also have the relevant passages of the regulations directly at hand for each topic. This allows you to compare the requirements directly and saves valuable research time.One thing is certain: the knowledge portal answers your questions about the supply chain of medicinal products, active pharmaceutical ingredients and medical devices. You don't have to be an expert. Yet.You will find answers to your questions in the GMP:KnowHow Pharma Logistics (GDP). Where does GDP begin, where does GMP end? What does GDP-compliant mean? When do I also have to take GMP requirements into account? What permits do I need for certain activities? What requirements do I have to fulfil? What is the current legal basis? How am I covered? What authorizations do I have for my work, e.g. from my employer? Who is responsible — the client or the contractor? And many more What is the difference to the GMP Compliance Adviser? GMP:KnowHow Pharma Logistics (GDP) is a practical knowledge portal dedicated to Good Distribution Practice (GDP). It is a product that is independent of the GMP Compliance Adviser and concentrates on content that is essential for carriers of medicinal products, active pharmaceutical ingredients and medical devices as well as for logistics clients. The focus is on practical knowledge and how to apply it in your daily business. If necessary, the relevant regulations can be called up immediately alongside the practical knowledge, and you can see the relevant paragraphs at a glance. In addition, sample documents are available to help you make immediate progress. AuthorSimone Ferrante, currently Director Quality at Fisher Clinical Services, previously served as Head of Quality Control and Responsible Person (GDP) for the Grieshaber Group. She is also a long-standing author and GDP expert at GMP-Verlag.

delivery time appr. 2-5 workdays after receipt of payment
€610.00 net excl. VAT
E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

Why are GMP rules important for technicians and engineers? Technicians and engineers play a key role in ensuring compliance with Good Manufacturing Practice (GMP) standards. They are involved in critical activities such as: planning and construction of ventilation systems, maintenance of water treatment plants, calibration of measuring sensors. Therefore, they are jointly responsible for the quality of medicines and must ensure that their work complies with GMP standards.Your advantages: Fast familiarization with GMP topics in approx. 2 hours, time- and location-independent online training, printable personal certificate, 12-month access for initial and follow-up training, automatic updates in case of legal changes,content compliant with Article 7(4) of Directive 2003/94/EC.The Author This e-learning course was developed with the collaboration of Dipl.-Ing. Andreas Nuhn (D & B Pharmadesign GmbH).

delivery time appr. 2-5 workdays after receipt of payment
€245.00 net excl. VAT
GMP Fundamentals | A Step-by-Step Guide

GMP Fundamentals | A Step-by-Step Guide

This handbook is a practical and easy to read guideline, giving you a quick and comprehensive overview of the complex world of Good Manufacturing Practice (GMP) without the need of previously acquired knowledge. Some topics are: GMP: Purpose and basic pharmaceutical terms Laws, licenses and inspections Personnel: Responsibility and hygiene Standard Operating Procedures (SOP) and documentation Design of rooms and facilities Processing and packaging Quality control and market release Suppliers, storage and logistics (Good Distribution Practice = GDP) Alphabetical index and abbreviations Using practical examples and comparisons to every-day life will help to easy understand GMP regulations.GMP Fundamentals is a helpful guide which facilitates the entry into the GMP world and teaches the necessary basics.

delivery immediately after receipt of payment
€44.90 net excl. VAT